Patent · US Active

Met kinase inhibitors

US7880004B2 · kind B2 · utility

4Cited by
3References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 14, 2006
Grant dateFeb 1, 2011
Priority date—
Expiry dateNov 3, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention is directed to compounds that are useful for the treatment of cancer having the following Formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.